midazolam has been researched along with Epileptic Syndromes in 3 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
Epileptic Syndromes: EPILEPTIC SEIZURES that are of similar type and age of onset and have other similar features (e.g., clinical course, EEG findings, genetic association and neuropathology).
| Excerpt | Relevance | Reference |
|---|---|---|
| " Five patients were sedated with initial lorazepam dose, but this side effect resolved on dosage reduction." | 1.72 | Enteral lorazepam is a promising weaning strategy for midazolam-responsive febrile infection-related epilepsy syndrome (FIRES): a case series ( Chaitra, R; Jain, V; Konanki, R; Sharma, R; Srivastava, K, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Jain, V | 1 |
| Konanki, R | 1 |
| Chaitra, R | 1 |
| Srivastava, K | 1 |
| Sharma, R | 1 |
| Ohshita, N | 1 |
| Tsuji, K | 1 |
| Yoshida, H | 1 |
| Shibata, H | 1 |
| Matsuda, Y | 1 |
| Tsutsumi, YM | 1 |
| Momota, Y | 1 |
| Baba, S | 1 |
| Okanishi, T | 1 |
| Ohsugi, K | 1 |
| Suzumura, R | 1 |
| Niimi, K | 1 |
| Shimizu, S | 1 |
| Sakihama, H | 1 |
| Itamura, S | 1 |
| Hirano, K | 1 |
| Nishimura, M | 1 |
| Fujimoto, A | 1 |
| Enoki, H | 1 |
3 other studies available for midazolam and Epileptic Syndromes
| Article | Year |
|---|---|
Enteral lorazepam is a promising weaning strategy for midazolam-responsive febrile infection-related epilepsy syndrome (FIRES): a case series
Topics: Child; Drug Resistant Epilepsy; Encephalitis; Epileptic Syndromes; Humans; Lorazepam; Male; Midazola | 2022 |
Anesthetic Management of Patient With Dravet Syndrome: A Case Report.
Topics: Anesthetics; Child; Epilepsies, Myoclonic; Epileptic Syndromes; Female; Humans; Midazolam | 2019 |
Possible Role of High-Dose Barbiturates and Early Administration of Parenteral Ketogenic Diet for Reducing Development of Chronic Epilepsy in Febrile Infection-Related Epilepsy Syndrome: A Case Report.
Topics: Barbiturates; Child; Combined Modality Therapy; Diet, Ketogenic; Electroencephalography; Epileptic S | 2021 |